LAUKOVÁ, Jarmila, Alois KOZUBÍK, Jiřina HOFMANOVÁ, Jana NEKVINDOVÁ, P. SOVA, M.P. MOYER, J. EHRMANN and A.H. VACULOVA. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. Plos one. San Francisco: Public Library of Science, 2015, vol. 10, No 10, p. nestránkováno, 20 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0141020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells
Authors LAUKOVÁ, Jarmila (703 Slovakia, belonging to the institution), Alois KOZUBÍK (203 Czech Republic, belonging to the institution), Jiřina HOFMANOVÁ (203 Czech Republic, belonging to the institution), Jana NEKVINDOVÁ (203 Czech Republic), P. SOVA (203 Czech Republic), M.P. MOYER (840 United States of America), J. EHRMANN (203 Czech Republic) and A.H. VACULOVA (203 Czech Republic, guarantor).
Edition Plos one, San Francisco, Public Library of Science, 2015, 1932-6203.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.057
RIV identification code RIV/00216224:14310/15:00095868
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1371/journal.pone.0141020
UT WoS 000363249300023
Keywords in English ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; ANTITUMOR EFFICACY; DNA-DAMAGE; IN-VITRO; CISPLATIN; LA-12; INHIBITION; GROWTH; ADAMANTYLAMINE
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 13/4/2018 15:47.
Abstract
We demonstrated for the first time an outstanding ability of rosiglitazone to mediate a profound enhancement of LA-12-induced apoptosis associated with activation of mitochondrial pathway in human colon cancer cells. This effect was preferentially observed in the G1 cell cycle phase, independent on p53 and PPAR. proteins, and accompanied with significant changes of selected Bcl-2 family protein levels. Further stimulation of cooperative synergic cytotoxic action of rosiglitazone and LA-12 was demonstrated in the cells deficient for PTEN, where mitochondrial apoptotic pathway was more stimulated and G1-phase-associated dying was reinforced. Our results suggest that combined treatment with rosiglitazone and LA-12 might be promising anticancer strategy in colon-derived tumours regardless of their p53 status, and also favourable in those defective in PTEN function.
PrintDisplayed: 27/8/2024 10:11